0208 Mgt Trax
BioCentury & Getty Images

Management Tracks

Collins stepping down as Editas CEO, Mallon leaving Ironwood; plus Kite, Werewolf, Vedanta and more

Feb 9, 2021 | 3:00 AM GMT

Gene editing company Editas Medicine Inc. (NASDAQ:EDIT) said Chairman James Mullen will succeed Cynthia Collins as CEO after she steps down on Feb. 15.

Read the full 503 word article

How to gain access

Continue reading with a
two-week free trial.